Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000127906 | SCV000055221 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Gene |
RCV000127906 | SCV000171492 | benign | not specified | 2013-07-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000860327 | SCV001000347 | benign | Brugada syndrome 5 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000127906 | SCV005091717 | benign | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 32% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 30. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV004717059 | SCV005314862 | benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV000127906 | SCV001920519 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000127906 | SCV001926412 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000127906 | SCV001952056 | benign | not specified | no assertion criteria provided | clinical testing |